Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Pediatrics

Volumn 117, Issue 1, 2006, Pages

  Völkl, Thomas M K ^a   Simm, Diemud ^a   Beier, Christoph ^a   Dörr, Helmuth G ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

21 hydroxylase; BMI; Congenital adrenal hyperplasia; Leptin; Obesity

Indexed keywords

DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; LEPTIN; MINERALOCORTICOID; PREDNISONE;

ADOLESCENT; ARTICLE; BIRTH WEIGHT; BODY MASS; BONE AGE; BONE MATURATION; CHILD; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OBESITY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR; SALT LOSING NEPHRITIS; STEROID 21 MONOOXYGENASE DEFICIENCY; SUBSTITUTION THERAPY; AGE DETERMINATION; BLOOD; FAMILY HEALTH; GENETICS; PRESCHOOL CHILD;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; AGE DETERMINATION BY SKELETON; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; LEPTIN; MALE; OBESITY;

EID: 33644836314     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-1005     Document Type: Article

References (35)

1. Hughes IA. Congenital adrenal hyperplasia: a continuum of disorders. Lancet. 1998;352:752-754
2. New MI. An update of congenital adrenal hyperplasia. Ann NY Acad Sci. 2004;1038:14-43
3. Knorr D, Hinrichsen-de-Lienau SG. Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy. Acta Paediatr Jpn. 1988;30(suppl):89-92
4. Cornean RE, Hindmarsh PC, Brook CG. Obesity in 21-hydroxylase deficient patients. Arch Dis Child. 1998;78:261-263
5. Blum WF, Kiess W, Rascher W. Leptin: The Voice of Adipose Tissue. Heidelberg, Germany: Johann Ambrosius Barth Verlag; 1997
6. Poyrazoglu S, Gunoz H, Darendeliler F. Serum leptin levels in patients with 21-hydroxylase deficiency before and after treatment. Turk J Pediatr. 2003;45:33-38
7. Charmandari E, Weise M, Bornstein SR, et al. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab. 2002;87:2114-2120
8. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res. 2002;58:188-195
9. Hauffa BP, Winter A, Stolecke H. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency. Klin Padiatr. 1997;209:71-77
10. Cunha HM, Elias LLK, Camacho-Hubner C, Moreira AC, Martinelli CE. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol. 2004;61:94-101
11. Krüger C, Rauh M, Dörr HG. Immunoreactive renin concentrations in healthy children from birth to adolescence. Clin Chim Acta. 1998;274:15-27
12. Knorr D, Bidlingmaier F, Kuhnle U. Diagnosis and monitoring of therapy of the various enzymatic defects causing congenital adrenal hyperplasia by semiautomatic capillary gas-liquid chromatography. Horm Res. 1982;16:201-208
13. Reinken L, Stolley H, Droese W, van Oost G. Longitudinal data of physical growth of healthy children, II: height, weight, skinfold thickness of children aged 1.5-16 years. Klin Padiatr. 1980;192:25-33
14. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Percentiles of body mass index for children and adolescents evaluated from different regional German studies [in German]. Monatsschr Kinderheilkd. 2001;149:807-818
15. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations: the Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics. 1998;102(3). Available at: www.pediatrics.org/cgi/content/ full/102/3/e29
16. Bellizzi MC, Dietz WH. Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr. 1999;70:173S-175S
17. Wabitsch M. Obesity in childhood and adolescence: recommendations of a United States of America Task Force for diagnosis and therapy. Klin Padiatr. 2000;212:287-296
18. World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-253
19. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P. An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand. 1991;80:756-762
20. Groell R, Lindbichler F, Riepl T, Gherra L, Roposch A, Fotter R. The reliability of bone age determination in central European children using the Greulich and Pyle method. Br J Radiol. 1999;72:461-464
21. Blum WF, Englaro P, Hanitsch S, et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab. 1997;82:2904-2910
22. von Kries R. Obesity among Bavarian children: experiences from school admittance examinations. Gesundheitswesen. 2004;66(suppl 1):S80-S85
23. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child. 1995;73:25-29
24. Roche EF, Charmandari E, Dattani MT, Hindmarsh PC. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clin Endocrinol (Oxf). 2003;58:589-596
25. Barker DJ. The developmental origins of adult disease. Eur J Epidemiol. 2003;18:733-736
26. Sayer AA, Syddall HE, Dennison EM, et al. Birth weight, weight at 1 y of age, and body composition in older men: findings from the Hertfordshire Cohort Study. Am J Clin Nutr. 2004;80:199-203
27. Matthews SG. Early programming of the hypothalamopituitary-adrenal axis. Trends Endocrinol Metab. 2002;13:373-380
28. Frisch H, Waldhauser F, Lebl J, et al. Congenital adrenal hyperplasia: lessons from a multinational study. Horm Res. 2002;57(suppl 2):95-101
29. Loos RJ, Bouchard C. Obesity: is it a genetic disorder? J Intern Med. 2003;254:401-425
30. Snyder EE, Walts B, Perusse L, et al. The human obesity gene map: the 2003 update. Obes Res. 2004;12:369-439
31. Beck B. Neuropeptides and obesity. Nutrition. 2000;16:916-923
32. Sandoval DA, Davis SN. Leptin: metabolic control and regulation. J Diabetes Complications. 2003;17:108-113
33. Masuzaki H, Ogawa Y, Hosoda K, et al. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab. 1997;82:2542-2547
34. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology. 1997;138:3859-3863
35. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250-252